Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

EAN 2017 | ASL MRI as an early biomarker for Alzheimer’s disease

Name: ASL MRI as an early biomarker for Alzheimer’s disease
Uploaded: 2017-06-24T00:00:00Z
Duration: 3 min 7 s
Description: M. Hale Alpsan Gökmen, MD from the Anadolu Health Center, Gebze, Turkey discusses a study on arterial spin labeling (ASL) MRI as an early biomarker for Alzheimer’s disease. Dr Gökmen emphasizes the importance of diagnosing patients early and summarizes the findings of their study. Recorded at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands.

M. Hale Alpsan Gökmen • 24 Jun 2017

EAN 2017

Alzheimer’s Disease

M. Hale Alpsan Gökmen, MD from the Anadolu Health Center, Gebze, Turkey discusses a study on arterial spin labeling (ASL) MRI as an early biomarker for Alzheimer’s disease. Dr Gökmen emphasizes the importance of diagnosing patients early and summarizes the findings of their study.
Recorded at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands.